Bonn Education Association for Dietetics r.A., Cologne, Germany Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2004
NCT03109834
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bonn Education Association for Dietetics r.A., Cologne, Germany

Active Ingredients

Drugs in Phase 3 Trials (2)

amino acids (Freamine) (1 trial)

betahistine mesilate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 3)

Nervous System Diseases (Phase 3)

Overweight (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2